Details for 2017000383
Up to date per 02.04.2026
Actions
Details for 2017000383
Granted/Registered
European Patent
22.11.2017 A
20.03.2024 B1
13.07.2011
EP
11005722
13.07.2011
US
201161507153 P
A61P 1/16 20060101AFI20170926BHEP
Owner
Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
Kinzel, OlafAm Hackteufel 8 69117 HeidelbergDE
Steeneck, Christophc/o Phenex Pharmaceuticals AG Donnersbergweg 1 67059 LudwigshafenDE
Kremoser, ClausGugenmusweg 20 69121 HeidelbergDE
Information about Fees